All
Images
Videos
News
Maps
English (UK)
čeština
Dansk
Deutsch (Deutschland)
Deutsch (Österreich)
Eesti
English (Australia)
English (Canada)
English (Cyprus)
English (India)
English (Ireland)
English (New Zealand)
English (Phillipines)
English (Singapore)
English (UK)
English (US)
Español (Argentina)
Español (Chile)
Español (Colombia)
Español (España)
Español (México)
Español (Perú)
Español (Venezuela)
français (Belgique)
français (France)
Hrvatski
italiano
latviešu valoda
Lëtzebuergesch
lietuvių kalba
limba română
magyar
Malti
Nederlands
Norsk
polski
português (Brazil)
português (Portugal)
Schwyzerdütsch
slovenčina
slovenščina
Suomi
Svenska
tiếng việt
ελληνικά
български
ภาษาไทย
中文 (台灣)
中文 (香港)
한국어
日本語
Bahasa Indonesia
Bahasa melayu
Anytime
Anytime
Past Day
Past Week
Past Month
SafeSearch: On
On
Off
News Search is powered by Bing, which is subject to the
Microsoft Privacy Statement
. No personal information is sent to Microsoft.
The McDuffie Progress
Tiny rare rodents given all-clear after being checked out by vets
Ten tiny rare hazel dormice have been given the all-clear by wildlife vets at conservation charity ZSL, ahead of their release into the wild next month.
15 hours ago
Daily Excelsior
Long Duration Funds: The power of time, the potential of growth
In the world of investments, the journey towards financial freedom is often a long one. It’s a marathon, not a sprint, and it’s essential to have a solid strategy that can withstand the ups and downs of the market over time.
20 hours ago
London Evening Standard on MSN.com
Big City development thwarted by men with tiny paintbrushes
The UK economy is dealing with sclerosis of old age, and unable to politically chart the trade-offs.” Those were the thoughts this week of top economist Simon French.
6 days ago
Space on MSN.com
'God of Destruction' asteroid Apophis will come to Earth in 2029 — and it could meet some tiny spacecraft
Asteroid Apophis is heading to Earth, and scientists have revealed three tiny spacecraft concepts that could race to meet the space rock in April 2029.
2 weeks ago
Pharm Exec
FDA Grants Accelerated Approval to Amgen’s Imdelltra for the Treatment of Adults with Extensive-Stage Small Cell Lung Cancer
Imdelltra (tarlatamab-dlle) is the first T-cell engager therapy approved for extensive stage small cell lung cancer.
15 hours ago
Tom's Guide
Best small phones 2024
The best small phones are a dying breed these days, but if you don't want your device to take up any more room in your bag or pocket, there are still options out there for you. We're not sure how ...
2 weeks ago
Benzinga.com on MSN.com
FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients
Less than 3% of patients with extensive-stage small cell lung cancer live longer than five years ... Imdelltra has received accelerated approval based on the response rate and duration of response (DoR) observed in clinical studies.
17 hours ago
Medscape
FDA Approves Tarlatamab for Extensive-Stage Small Cell Lung Cancer
Continued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit.
2 days ago
Pharmabiz
Amgen’s Imdelltra receives US FDA approval to treat adult patients with extensive-stage small cell lung cancer
Amgen’s Imdelltra receives US FDA approval to treat adult patients with extensive-stage small cell lung cancer: Thousand Oaks Saturday, May 18, 2024, 11:00 Hrs [IST] Amgen annou
1 hour ago
YAHOO!Finance
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.
2 days ago
Next >
Privacy
Terms
About